REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
04/27/2026
Back to search
Official data from USPTO
SHIPHRAH BIOMEDICAL INC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
15
Latest update
04/28/2026
Trademark type
Combined
Nice classes
42
Filing date
07/01/2020
Registration date
04/27/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/27/2021
Last transaction
04/28/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
10/01/2019
First use in commerce
06/28/2020
Drawing code
5
Owner type
03
Owner location
Toronto, ON, CA
Examiner
SINGH, TEJBIR
Law office
L60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the term Shiphrah in blue that is positioned above 'BIOMEDICAL inc' which is in grey, and a portion of the letter P in Shiphrah is positioned to the left of and below 'BIOMEDICAL inc'.
Holders and representatives
Holders
Shiphrah Biomedical Inc.
Representatives
Thomas Tatonetti TATONETTI IP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Design and development of medical devices; Conducting clinical trials for others for the development of medical devices
Publications
History of USPTO decisions and trademark events.
15 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
04/27/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/09/2021
PUBO
PUBLISHED FOR OPPOSITION
02/09/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/20/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/04/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/11/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/10/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/10/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/07/2020
GNRT
NON-FINAL ACTION E-MAILED
10/07/2020
CNRT
NON-FINAL ACTION WRITTEN
10/07/2020
DOCK
ASSIGNED TO EXAMINER
10/07/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/28/2020
NWAP
NEW APPLICATION ENTERED
07/04/2020
Continuous trademark protection
Get notified about every new filing that threatens SHIPHRAH BIOMEDICAL INC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.